Most recent by Rosna Mirtcheva, MD
Purine analogs provide first-line defense against HCL
Benign inflammatory lesion of the reconstructed breast: a diagnostic challenge
A 40-year-old woman presented to our hospital with a painless right axillary mass with duration of two months. Her history included stage IIA right breast cancer diagnosed 18 months prior. She underwent mastectomy and sentinel lymph node sampling followed by immediate transverse rectus abdominis muscle reconstruction. The tumor was a multifocal, moderately differentiated infiltrating lobular carcinoma with extensive ductal carcinoma in situ, and nonsentinel lymph node from the right axillary tail of the breast was positive for macrometastasis. The tumor was ER-positive, PR-positive and HER-2/neu-negative. She received adjuvant chemotherapy with four cycles of dose dense doxorubicin and cyclophosphamide and is currently on adjuvant hormonal therapy with tamoxifen.